Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ibrahim M Ibrahim

Showing results (121-130 of 176) with videos related to

Pageof 18
Sort By:
Chemistryopen|October 6, 2023
A Theobromine Derivative with Anticancer Properties Targeting VEGFR-2: Semisynthesis, in silico and in vitro StudiesIbrahim H Eissa, Reda G Yousef, Hazem Elkady, et al.
Future Medicinal Chemistry|May 9, 2024
Harnessing molecular hybridization approach to discover novel quinoline EGFR-TK inhibitors for cancer treatmentNoha Ryad, Ayman Abo Elmaaty, Ibrahim M Ibrahim, et al.
Pathology, Research and Practice|October 19, 2023
Anti-breast cancer potential of a new xanthine derivative: In silico, antiproliferative, selectivity, VEGFR-2 inhibition, apoptosis induction and migration inhibition studiesIbrahim H Eissa, Reda G Yousef, Hazem Elkady, et al.
Computers in Biology and Medicine|July 31, 2021
Structure-based virtual screening suggests inhibitors of 3-Chymotrypsin-Like Protease of SARS-CoV-2 from Vernonia amygdalina and Occinum gratissimumGideon A Gyebi, Abdo A Elfiky, Oludare M Ogunyemi, et al.
Current Pharmaceutical Design|November 30, 2023
Design, Molecular Modeling, MD Simulations, Essential Dynamics, ADMET, DFT, Synthesis, Anti-proliferative, and Apoptotic Evaluations of a New Anti-VEGFR-2 Nicotinamide AnalogueIbrahim H Eissa, Eslam B Elkaeed, Hazem Elkady, et al.
Molecules (Basel, Switzerland)|July 27, 2022
Design, Synthesis, Docking, DFT, MD Simulation Studies of a New Nicotinamide-Based Derivative: In Vitro Anticancer and VEGFR-2 Inhibitory EffectsEslam B Elkaeed, Reda G Yousef, Hazem Elkady, et al.
Nanomaterials (Basel, Switzerland)|November 27, 2021
A Multifunctional Polymeric Micelle for Targeted Delivery of Paclitaxel by the Inhibition of the P-Glycoprotein TransportersSobia Razzaq, Aisha Rauf, Abida Raza, et al.
Evolutionary Bioinformatics Online|December 4, 2023
Computer-Assisted Drug Discovery of a Novel Theobromine Derivative as an EGFR Protein-Targeted Apoptosis InducerIbrahim H Eissa, Reda G Yousef, Eslam B Elkaeed, et al.
Journal of Biomolecular Structure & Dynamics|October 2, 2022
<i>In silico</i>, <i>in vitro</i> VEGFR-2 inhibition, and anticancer activity of a 3-(hydrazonomethyl)naphthalene-2-ol derivativeEslam B Elkaeed, Reda G Yousef, Hazem Elkady, et al.
Computational Biology and Chemistry|September 6, 2023
Design, semi-synthesis, anti-cancer assessment, docking, MD simulation, and DFT studies of novel theobromine-based derivatives as VEGFR-2 inhibitors and apoptosis inducersIbrahim H Eissa, Reda G Yousef, Hazem Elkady, et al.
Pageof 18

Showing results (121-130 of 176) with videos related to

Sort By:
Pageof 18
Chemistryopen|October 6, 2023
A Theobromine Derivative with Anticancer Properties Targeting VEGFR-2: Semisynthesis, in silico and in vitro StudiesIbrahim H Eissa, Reda G Yousef, Hazem Elkady, et al.
Future Medicinal Chemistry|May 9, 2024
Harnessing molecular hybridization approach to discover novel quinoline EGFR-TK inhibitors for cancer treatmentNoha Ryad, Ayman Abo Elmaaty, Ibrahim M Ibrahim, et al.
Pathology, Research and Practice|October 19, 2023
Anti-breast cancer potential of a new xanthine derivative: In silico, antiproliferative, selectivity, VEGFR-2 inhibition, apoptosis induction and migration inhibition studiesIbrahim H Eissa, Reda G Yousef, Hazem Elkady, et al.
Computers in Biology and Medicine|July 31, 2021
Structure-based virtual screening suggests inhibitors of 3-Chymotrypsin-Like Protease of SARS-CoV-2 from Vernonia amygdalina and Occinum gratissimumGideon A Gyebi, Abdo A Elfiky, Oludare M Ogunyemi, et al.
Current Pharmaceutical Design|November 30, 2023
Design, Molecular Modeling, MD Simulations, Essential Dynamics, ADMET, DFT, Synthesis, Anti-proliferative, and Apoptotic Evaluations of a New Anti-VEGFR-2 Nicotinamide AnalogueIbrahim H Eissa, Eslam B Elkaeed, Hazem Elkady, et al.
Molecules (Basel, Switzerland)|July 27, 2022
Design, Synthesis, Docking, DFT, MD Simulation Studies of a New Nicotinamide-Based Derivative: In Vitro Anticancer and VEGFR-2 Inhibitory EffectsEslam B Elkaeed, Reda G Yousef, Hazem Elkady, et al.
Nanomaterials (Basel, Switzerland)|November 27, 2021
A Multifunctional Polymeric Micelle for Targeted Delivery of Paclitaxel by the Inhibition of the P-Glycoprotein TransportersSobia Razzaq, Aisha Rauf, Abida Raza, et al.
Evolutionary Bioinformatics Online|December 4, 2023
Computer-Assisted Drug Discovery of a Novel Theobromine Derivative as an EGFR Protein-Targeted Apoptosis InducerIbrahim H Eissa, Reda G Yousef, Eslam B Elkaeed, et al.
Journal of Biomolecular Structure & Dynamics|October 2, 2022
<i>In silico</i>, <i>in vitro</i> VEGFR-2 inhibition, and anticancer activity of a 3-(hydrazonomethyl)naphthalene-2-ol derivativeEslam B Elkaeed, Reda G Yousef, Hazem Elkady, et al.
Computational Biology and Chemistry|September 6, 2023
Design, semi-synthesis, anti-cancer assessment, docking, MD simulation, and DFT studies of novel theobromine-based derivatives as VEGFR-2 inhibitors and apoptosis inducersIbrahim H Eissa, Reda G Yousef, Hazem Elkady, et al.
Pageof 18